Siga Technologies Inc 8-K, filed Sep 9, 2021
Siga Technologies Inc (SIGA)
8-K
2021-09-09
For: 2021-09-07
View Original
Added on
April 10, 2026
About this 8-K
Siga Technologies Inc filed this 8-K on September 9, 2021, reporting on events of September 7, 2021.
Items reported
- Item 8.01: Other events
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 7, 2021
(Exact name of registrant as specified in its charter)
|
|
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(Commission file number)
|
(I.R.S. employer identification no.)
|
|
(Address of principal executive offices)
|
(Zip code) |
Registrant’s telephone number, including area code: (212 ) 672-9100
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter)
or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 8.01 |
Other Events.
|
On September 7, 2021, the U.S. Government exercised a procurement option under the 19C
Biomedical Advanced Research and Development Authority (BARDA) contract with SIGA Technologies, Inc. for the delivery of approximately $112.5 million of oral TPOXX courses to the U.S. Government. Product deliveries in connection with the option
exercise are targeted for 2021. The option exercise was also disclosed in the Federal Procurement Data System.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this
report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
SIGA TECHNOLOGIES, INC.
|
||
|
|
|
||
|
|
By:
|
/s/ Daniel J. Luckshire
|
|
|
|
Name:
|
Daniel J. Luckshire
|
|
|
|
Title:
|
Chief Financial Officer
|
|
|
|
|
|
|
|
Date: September 9, 2021
|
|
|
|